OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current Evidence for Combined Targeted Therapy for the Treatment of Inflammatory Bowel Disease
Panu Wetwittayakhlang, Péter L. Lakatos
Journal of the Canadian Association of Gastroenterology (2023) Vol. 7, Iss. 1, pp. 22-29
Open Access | Times Cited: 12
Panu Wetwittayakhlang, Péter L. Lakatos
Journal of the Canadian Association of Gastroenterology (2023) Vol. 7, Iss. 1, pp. 22-29
Open Access | Times Cited: 12
Showing 12 citing articles:
Efficacy and safety of dual-targeted therapy for inflammatory bowel disease: a retrospective multicenter study in China
Xin Jin, Kefang Sun, Liying Wang, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access | Times Cited: 2
Xin Jin, Kefang Sun, Liying Wang, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access | Times Cited: 2
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease
Pierluigi Puca, I. Capobianco, Gaetano Coppola, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2789-2789
Open Access | Times Cited: 6
Pierluigi Puca, I. Capobianco, Gaetano Coppola, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2789-2789
Open Access | Times Cited: 6
Cytokine Profile in Predicting the Effectiveness of Advanced Therapy for Ulcerative Colitis: A Narrative Review
Hiroki Kurumi, Yoshihiro Yokoyama, Takehiro Hirano, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 952-952
Open Access | Times Cited: 5
Hiroki Kurumi, Yoshihiro Yokoyama, Takehiro Hirano, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 952-952
Open Access | Times Cited: 5
Combining Advanced Targeted Therapy in Inflammatory Bowel Disease: Current Practice and Future Directions
A. De Bernardi, Cristina Bezzio, Michele Puricelli, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 590-590
Open Access
A. De Bernardi, Cristina Bezzio, Michele Puricelli, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 590-590
Open Access
Biobetters and biosimilars in Inflammatory Bowel Disease
Jacopo Fanizza, Ilaria Faggiani, Mariangela Allocca, et al.
Best Practice & Research Clinical Gastroenterology (2025), pp. 101992-101992
Closed Access
Jacopo Fanizza, Ilaria Faggiani, Mariangela Allocca, et al.
Best Practice & Research Clinical Gastroenterology (2025), pp. 101992-101992
Closed Access
Combining mechanistic modeling with machine learning as a strategy to predict inflammatory bowel disease clinical scores
Jaehee V. Shim, Markus Rehberg, Britta Wagenhuber, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Jaehee V. Shim, Markus Rehberg, Britta Wagenhuber, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Treatment sequencing in inflammatory bowel disease : towards clinical precision medicine
Léa Sequier, Bénédicte Caron, Sailish Honap, et al.
Best Practice & Research Clinical Gastroenterology (2025), pp. 101994-101994
Closed Access
Léa Sequier, Bénédicte Caron, Sailish Honap, et al.
Best Practice & Research Clinical Gastroenterology (2025), pp. 101994-101994
Closed Access
Real-World Outcomes of Dual Advanced Therapy in Children and Young Adults with Inflammatory Bowel Disease
Amelia Kellar, Michael Dolinger, Elizabeth Spencer, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 5, pp. 1826-1833
Closed Access | Times Cited: 4
Amelia Kellar, Michael Dolinger, Elizabeth Spencer, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 5, pp. 1826-1833
Closed Access | Times Cited: 4
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey
Marta Vernero, Cristina Bezzio, Davide Giuseppe Ribaldone, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1857-1857
Open Access | Times Cited: 1
Marta Vernero, Cristina Bezzio, Davide Giuseppe Ribaldone, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1857-1857
Open Access | Times Cited: 1
Inflammation in Health and Disease: Novel Therapeutic Approaches
M. Ganga Raju, G. Kaveri, N.V. L.V. Suvarchala Reddy, et al.
International Journal of Innovative Science and Research Technology (IJISRT) (2024), pp. 990-994
Open Access | Times Cited: 1
M. Ganga Raju, G. Kaveri, N.V. L.V. Suvarchala Reddy, et al.
International Journal of Innovative Science and Research Technology (IJISRT) (2024), pp. 990-994
Open Access | Times Cited: 1
Histopathological outcome predictors of quiescence/remission in inflammatory bowel diseases: A need being addressed
Vincenzo Villanacci, Gabrio Bassotti
United European Gastroenterology Journal (2024)
Open Access | Times Cited: 1
Vincenzo Villanacci, Gabrio Bassotti
United European Gastroenterology Journal (2024)
Open Access | Times Cited: 1
Persistence of newly prescribed 5-aminosalicylic acid in patients with ulcerative colitis: A nationwide comprehensive database study
Tatsuya Noda, Kotaro Kuwaki, Munehito Machida, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0316181-e0316181
Open Access
Tatsuya Noda, Kotaro Kuwaki, Munehito Machida, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0316181-e0316181
Open Access
